- Frequent history of heartburn was associated with higher risk for throat and vocal cord cancers.
- Evidence has been found that pazopanib, a drug used to treat kidney cancer, may prevent relapse of ovarian cancer.
- Colorectal cancers that are anti-EGFR resistant might be effectively treated with MET inhibitors.
- An experimental drug, lambrolizumab, shrank tumors in 38% of patients with advanced melanoma.
- Breakthrough therapies in cancer are being put on the fast track in FDA regulation.